Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suvratoxumab for Prevention of S. aureus Pneumonia (SAATELLITE)
NCT02296320Phase 2Completed
- Sponsor
- MedImmune
- Start
- Oct 2014
- Primary completion
- Oct 2018
- Modality
- Monoclonal Antibodies
- Countries
- 10
01
Overview
A Phase 2 trial of Suvratoxumab in Staphylococcus aureus pneumonia, sponsored by MedImmune. Started Oct 2014; status: completed.
02
Drugs
Suvratoxumab
03
Conditions
Staphylococcus aureus pneumonia
Beyond the preview
Go deeper on NCT02296320.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02296320.